Reading FMC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FMC free→Reading FMC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track FMC free→
NYSEMaterialsAgricultural InputsSnapshot 2026-06-16
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and earnings quality cannot be assessed since the company was unprofitable over the past year. Management's recent track record has been fairly steady, but risk is high, and the sector backdrop is a headwind, with FMC compared to sector peers being below typical. Peer multiples imply a price roughly in line with where it trades (about fair); the read is fair, but weakening. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $11.61. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $12 FMC trades at 22× p/e, in line with its 21× p/e peer median. Our $12 fair value reflects that, high confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 0% near-term growth, ahead of our forecast of about -25%. This describes what's priced in, not a forecast of the move.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated weak grew net income 51% of the time over the next year (vs 59% for the rest of the cohort, n=1088).
Over the trailing year it converted 0.02x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates.
7 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 54% for the rest of the cohort, n=272).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.21 → $0.21 (+0.0% / 30d). 1 raised, 13 cut, 15 covering analysts.
0 upgrades, 0 downgrades / 30d. 24% of analysts rate Buy.
2 positive, 2 negative / 30d. See F4 management tile for the event list.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 0% of the last 1 guided quarters · -200.0% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$259.
How much price usually moves either way.
On a bad day, this stock has moved -$596.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $7,503.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Valuation label changed from 'full' to 'fair'.
The valuation changed. It moved from full to fair. Risk remained high. Earnings quality is still loss-making. The sector backdrop is a headwind.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: A bigger drop would show lower demand and more pricing pressure in the market.
Confirms:Q2 revenue guidance is below $850 million. This shows a bigger drop than expected.
Disproves:Q2 revenue guidance is at or above $850 million. This suggests things are stabilizing.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
Advances: Explore strategic options including potential sale
Sale of India business aligns with strategic options exploration.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Entry into a Material Definitive Agreement. On June 5, 2026, FMC Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $1.2 billion aggregate principal amount of its 8.000% Senior Secured Notes due 2031 (the “Notes”). The Notes were sold under a purchase agreement, dated as of May 21, 2026, entered into by and among the Company, the Subsidiary Guarantors (as defined below) party thereto and Citigroup Global Markets Inc., as representative of the s…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Roughly priced in line with peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Materials (broad).
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
FMC FMC Corporation | Below typical Show detailsSector percentile: 23 of 100 | fair | high |
RS Reliance, Inc. | Above typical Show detailsSector percentile: 78 of 100 | full | moderate |
RGLD Royal Gold | Typical Show detailsSector percentile: 66 of 100 | full | moderate |
AA Alcoa | Typical Show detailsSector percentile: 68 of 100 | fair | elevated |
RPM RPM International | Above typical Show detailsSector percentile: 73 of 100 | fair | moderate |
Not investment advice. As of 2026-06-16.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
FMC aims to strengthen its balance sheet by reducing debt by $1 billion through asset sales and licensing agreements.
The FMC Board has authorized the exploration of strategic options, including a potential sale of the company.
FMC is focused on driving growth of new active ingredients, including Isoflex, fluindapyr, and Dodhylex.
FMC announced a proposed offering of $750 million in senior secured notes to fund a share buyback program.
FMC aims to manage operating income despite reporting losses in recent quarters.
Why it matters: Closing this offering will help FMC reduce debt and strengthen its balance sheet.
Confirms:The offering closes on June 5, 2026, with funds allocated for debt repayment.
Disproves:The offering fails to close or is delayed beyond June 5, 2026.
Why it matters: Successful debt reduction would strengthen the balance sheet and improve financial health.
Confirms:FMC announces a reduction in total debt by at least $250 million within the next quarter.
Disproves:No major debt reduction is reported. This shows problems in managing finances.
Why it matters: Progress on strategic options could lead to significant changes for FMC.
Confirms:Management shares a final deal from the review.
Disproves:No news or a statement that the evaluation has stopped.
Why it matters: Details on the buyback may show management's trust in the company's value.
Confirms:FMC shares details on the buyback program, like timing and amount.
Disproves:No further details are provided, or the buyback is canceled.
Why it matters: A share buyback would signal management's confidence in the company's future. It could also support the stock price.
Confirms:A formal announcement of a share buyback program with a set dollar amount.
Disproves:No announcement of a buyback program or a delay in plans.
Why it matters: The results will show if FMC can stabilize revenue amid declining trends.
Confirms one read:Q2 revenue is over $850 million. This shows better performance than expected.
Confirms the other:Q2 revenue is under $850 million. This confirms a drop in revenue.
Why it matters: Fixing negative cash flow is key for financial health. Positive cash flow shows better performance.
Confirms:Cash flow from operations turns positive for the next quarter.
Disproves:Cash flow from operations remains negative or worsens.
Why it matters: Better operating income shows good cost management. This can help stabilize the company.
Confirms:Operating income is better than last quarter. It is getting closer to breakeven.
Disproves:Operating income is still going down from last quarter.
Advances: Strengthen balance sheet by reducing debt by $1B
Debt paydown target supports balance sheet strengthening objective.
Advances: Drive growth of new active ingredients
Approval for Isoflex supports growth of new active ingredients.
Advances: Drive growth of new active ingredients
EU approval for Isoflex enhances product growth potential.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that are “forward-looking” and provide other than historical information, including statements contained in this Current Report, in FMC’s other filings with the SEC, and in presentations, reports or letters to FMC stockholders. In some cases, FMC has identified these forward-looking statements by such words or phr…
Other Events. On May 21, 2026, FMC issued a press release announcing the pricing of its previously announced offering of $1.2 billion aggregate principal amount of its 8.000%% Senior Secured Notes due 2031. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: FMC and its representatives may from time to time make written or oral statements that…
Other Events. On May 19, 2026, FMC Corporation (the “Company”) announced a proposed offering of $750.0 million aggregate principal amount of senior secured notes due 2031 (the “Notes”) in a private offering (the “Offering”) to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to non-U.S. persons outside of the United States pursuant to Regulation S under the Securities Act. The Not…
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 29, 2026, FMC Corporation issued a press release announcing the financial results for the three months ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.